ONCOFoCUS Febrile Neutropenia

ONCOFoCUS Febrile Neutropenia Risk Assessment. The application allows you to assess if a patient undergoing chemotherapy is at risk of febrile neutropenia. Through a series of standardised questions based on EORTC and NCCN guidelines, the tool asks you to consider the numerous factors that may contribute to an increased risk. Benefits.